Maunank Shah
@maunankshah1
Followers
122
Following
773
Media
2
Statuses
384
RT @PaulSaxMD: In a beautifully structured, moving example from our new Voices of ID series in @CIDJournal, Dr. @GretchenArnoczy looks back….
0
13
0
RT @CDCMMWR: New CDC MMWR on an MDR TB outbreak in a state with few reported TB infections: Be aware of higher ra….
0
3
0
RT @CIDJournal: 🆕 State-of-the-Art Review: Neurosyphilis 🆕. ✅ Just Accepted.🆓 Freely Available.
academic.oup.com
Abstract. We review key concepts in the diagnosis, treatment, and follow-up of individuals with neurosyphilis. We describe the epidemiology of syphilis in
0
19
0
RT @CIDJournal: Effectiveness of adjunctive high dose infliximab therapy to improve disability free survival among patients with severe CNS….
0
8
0
RT @CIDJournal: Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Ut….
0
3
0
RT @CIDJournal: Increased lung cancer risk and associated risk factors in tuberculosis survivors: A Korean population-based study. ✅ Just A….
0
7
0
RT @PaulSaxMD: Virologic failure despite adherence to CAB-RPV is rare (1%), but it happens, with bad consequences (INSTI and NNRTI resistan….
academic.oup.com
Confirmed virologic failure occurred in 1.4% of long-acting cabotegravir + rilpivirine participants up to 3 years on study. Having ≥2 baseline factors (ril
0
42
0
RT @CIDJournal: 🆕 State of the Art Review. In this narrative review, Nicolas W Cortes-Penfield, and colleagues, bring together experts in i….
academic.oup.com
Diabetes-related foot ulcers (DFUs) have a global prevalence of 6.3%, reaching 13% in North America [1]. DFUs have a dismal prognosis, with 5- and 10-year
0
7
0
RT @CIDJournal: Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-….
academic.oup.com
An all-oral 6-month regimen of bedaquiline, pretomanid, and linezolid (BPaL) was implemented in the United States to treat rifampin-resistant and rifampin-
0
18
0
Great data that shows how rapidly new regimens are being adopted for DR-TB. Congratulations to Connie and the team for pulling this data together. Looking forward to @tbcontrollers conference in June to discuss.
Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease. ✅ Just Accepted.🆓 Freely Available.
0
0
1
RT @CIDJournal: Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities. 🗨️ Editorial Commentary.🔗 https://….
0
7
0
RT @DrBike7: People with baseline high plama HIV-1 RNA and low CD4 counts have an increased risk of RV, LLV and virol failure with every AR….
0
11
0
RT @CIDJournal: Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds. ✅….
academic.oup.com
Tuberculosis leads to income and nonincome losses for people and their households. Current measures are one-dimensional and money centric and are benchmark
0
2
0
This is great advice!.
Some really good tips below, especially for early-career investigators. As an Associate Editor / Deputy Editor for @OFIDJournal and now @JIDJournal, here are my top 10 (hard-earned) tips to help make your manuscript submission/review process go as smoothly as possible: a🧵.
0
0
2
RT @CIDJournal: Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019. 🆓 Freely Available.ht….
academic.oup.com
In this observational analysis of real-world data, treatment with nirmatrelvir plus ritonavir in nonhospitalized vaccinated patients at high risk of diseas
0
9
0
RT @DrJLi: Our paper on symptom and viral rebound is now out in @AnnalsofIM and was just presented by the lead author @DeoR83 at #CROI2023.….
acpjournals.org
Background: Although symptom and viral rebound have been reported after nirmatrelvir–ritonavir treatment, the trajectories of symptoms and viral load during the natural course of COVID-19 have not...
0
14
0
RT @CarlosdelRio7: Great talk on viral rebound after COVID by @DrJLi at #CROI2023 Viral & symptom rebound can occur after infection & aft….
0
7
0
RT @PaulSaxMD: Many years ago, I got an unsolicited call from the Chief of Medicine at UCSF, telling me about a "brilliant, hard working, a….
0
1
0